Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Raxium-DSR Rabeprazole Sodium Domperidone Capsules
Raxium-DSR Rabeprazole Sodium Domperidone Capsules is a combination medication used to treat gastroesophageal reflux disease (GERD) and other conditions involving excessive stomach acid and delayed gastric emptying. Rabeprazole is a proton pump inhibitor (PPI) that reduces stomach acid production, while Domperidone is a prokinetic agent that enhances gastrointestinal motility.
Uses of Raxium-DSR Rabeprazole Sodium Domperidone Capsules
Managing gastroesophageal reflux disease (GERD)
Treating Zollinger-Ellison syndrome
Alleviating symptoms of dyspepsia and heartburn
Preventing nausea and vomiting associated with delayed gastric emptying
Benefits of Raxium-DSR Rabeprazole Sodium Domperidone Capsules
Effective Acid Reduction: Rabeprazole effectively reduces stomach acid production, providing relief from acid-related symptoms.
Enhanced Motility: Domperidone improves gastric emptying, reducing symptoms of bloating and nausea.
Comprehensive Treatment: Combines acid suppression and prokinetic action for holistic management of GERD and related conditions.
Symptom Relief: Alleviates heartburn, regurgitation, and other discomforts associated with acid reflux.
Mechanism of Action of Raxium-DSR Rabeprazole Sodium Domperidone Capsules
Rabeprazole works by inhibiting the H+/K+ ATPase enzyme in the stomach lining, which is responsible for acid secretion. This action significantly reduces the production of stomach acid, helping to heal and prevent damage to the esophagus and stomach lining caused by excessive acid. Domperidone, on the other hand, works by blocking dopamine receptors in the gastrointestinal tract. This increases the movements or contractions of the stomach and intestines, facilitating faster gastric emptying and reducing nausea. Together, Rabeprazole and Domperidone provide a synergistic effect in managing GERD and other related conditions by both reducing acid production and enhancing gastrointestinal motility.